Jazz Pharmaceuticals Plc (JAZZ)
170.73
+0.23
(+0.13%)
USD |
NASDAQ |
Dec 30, 15:00
Jazz Pharmaceuticals EPS Diluted (Quarterly): 4.081 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zymeworks, Inc. | -0.2587 |
| Alkermes Plc | 0.4911 |
| Medtronic Plc | 1.067 |
| Avadel Pharmaceuticals Plc | 0.0002 |
| Amarin Corp. Plc | -0.3702 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 251.41M |
| Revenue (Quarterly) | 1.126B |
| Total Expenses (Quarterly) | 874.70M |
| Enterprise Value | 13.74B |
| Gross Profit Margin (Quarterly) | 73.60% |
| Profit Margin (Quarterly) | 22.33% |
| Earnings Yield | -3.56% |
| Operating Earnings Yield | 4.94% |
| Normalized Earnings Yield | 3.267 |